简介 :BPR1K871 is a potent and selective dual FLT3/AURKA inhibitor with IC50s of 19 nM and 22 nM for FLT3 and AURKA, respectively, acts as a preclinical development candidate for anti-cancer therapy.
Catalog_No:HY-100865
Alternative_Names:DBPR114
产品一级分类:信号通路
二级分类:生命科学试剂
SMILES:O=C(NC1=CC(Cl)=CC=C1)NC2=NC=C(S2)CCNC3=NC=NC4=C3C=CC(OCCCN(C)C)=C4
Pathway:Protein Tyrosine Kinase/RTK
Target:FLT3
Research_Area:Cancer
国际站:BPR1K871